BCRX
BioCryst Pharmaceuticals Inc.
$7.32
+$0.07(+0.97%)
48
Overall
30
Value
54
Tech
60
Quality
Market Cap
$1.52B
Volume
5.73M
52W Range
$6.00 - $11.31
Target Price
$20.27
EPS Estimates Overview
| Current Quarter | $0.07 | Next Quarter | $0.03 |
| Current Year | $0.17 | Next Year | $0.39 |
| QoQ Growth | -57.1% | YoY Growth | +129.4% |
| 3Y EPS CAGR | +25.3% | Target Price | $20.27 |
| Consensus | Buy | Upside | +176.9% |
EPS Historical Trend (5 Years)
Quarterly EPS Estimates
Revenue Analysis
| Current Quarter Rev | N/A | Next Quarter Rev | N/A |
| Revenue Growth | N/A | YoY Growth | N/A |
Estimates are based on analyst consensus and subject to revision. Past performance does not guarantee future results.
| A | B | C | D | |
|---|---|---|---|---|
| 1 | Symbol | Price | Change | Vol |
| 2 | BCRX | $7.32 | +1.0% | 5.73M |
| 3 | ||||
| 4 | ||||
| 5 | ||||
| 6 |
Get BioCryst Pharmaceuticals Inc. Data in Excel
Stream real-time data directly to your spreadsheets
BUY NOW